REYON Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr '26 Apr 1, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	182,676	235,498	303,360	384,347	631,111	390,433
Market Cap Growth	-17.55%	-22.37%	-21.07%	-39.10%	61.64%	47.64%
Enterprise Value	388,377	381,553	498,164	550,681	726,725	401,156
Last Close Price	9960.00	12840.00	16540.00	21444.72	34972.84	21582.97
PE Ratio	-	56.73	84.66	52.23	116.61	101.56
PS Ratio	1.22	1.59	2.01	2.50	4.42	3.00
PB Ratio	0.78	0.94	1.22	1.55	2.57	1.70
P/TBV Ratio	0.79	0.95	1.23	1.56	2.59	1.71
P/OCF Ratio	-	-	35.09	44.03	54.01	84.89
EV/Sales Ratio	2.60	2.57	3.30	3.58	5.09	3.09
EV/EBITDA Ratio	-	71.21	76.00	61.31	117.02	64.51
EV/EBIT Ratio	-	-	281.00	123.81	470.45	242.53
Debt / Equity Ratio	0.92	0.82	0.91	0.85	0.85	0.26
Debt / EBITDA Ratio	181.50	38.08	34.33	23.40	33.38	9.56
Net Debt / Equity Ratio	0.88	0.78	0.81	0.70	0.45	0.06
Net Debt / EBITDA Ratio	174.25	36.18	30.64	19.39	17.69	2.25
Net Debt / FCF Ratio	-21.76	-11.11	-9.93	-3.20	-1.04	-0.29
Asset Turnover	0.31	0.30	0.31	0.32	0.36	0.44
Inventory Turnover	2.79	1.99	2.25	2.60	2.35	2.22
Quick Ratio	0.34	0.35	0.51	1.63	2.91	1.83
Current Ratio	0.60	0.66	0.80	2.27	3.47	2.42
Return on Equity (ROE)	-5.93%	1.67%	1.44%	3.02%	2.33%	1.70%
Return on Assets (ROA)	-3.35%	-0.12%	0.22%	0.58%	0.24%	0.35%
Return on Invested Capital (ROIC)	-5.92%	-0.18%	0.36%	1.15%	0.49%	0.66%
Return on Capital Employed (ROCE)	-7.70%	-0.30%	0.50%	1.00%	0.40%	0.60%
Earnings Yield	-7.80%	1.76%	1.18%	1.93%	0.88%	0.98%
FCF Yield	-5.17%	-7.41%	-6.67%	-14.16%	-16.68%	-12.22%
Dividend Yield	-	-	0.91%	0.70%	0.71%	0.93%
Payout Ratio	-	66.27%	76.41%	61.38%	62.56%	150.47%
Buyback Yield / Dilution	-0.83%	-	-0.46%	-3.03%	-4.05%	-1.01%
Total Shareholder Return	-0.83%	-	0.45%	-2.33%	-3.34%	-0.09%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.